Stay updated on DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial

Sign up to get notified when there's something new on the DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision changed from v3.7.2 to v3.8.0. The page still shows a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T01:59:56.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A banner was added announcing NIH website updates and saying that, during a transition, NIH content may use “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T02:02:28.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer's displayed ClinicalTrials.gov revision changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T01:43:55.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T02:10:58.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page, replacing the study content with a standard error layout. A minimal header/footer and a Home link are shown, indicating the page is not accessible at this time.
    Difference
    17%
    Check dated 2026-09-20T01:14:02.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    An NIH grant/contract funding entry for 2017 was added, and the revision tag was updated from v3.6.5 to v3.6.6. This also implies the page’s version history has advanced and reflects the newer revision along with the added funding information.
    Difference
    0.1%
    Check dated 2026-08-29T20:44:21.000Z thumbnail image

Stay in the know with updates to DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial page.